Journal
CRYSTAL GROWTH & DESIGN
Volume 16, Issue 8, Pages 4473-4481Publisher
AMER CHEMICAL SOC
DOI: 10.1021/acs.cgd.6b00606
Keywords
-
Funding
- NITK Surathkal
Ask authors/readers for more resources
Pharmaceutical cocrystals of an analgesic drug ethenzamide (ETZ) with various coformers, namely, gallic acid (GA), 2-nitrobenzoic acid (2NB), 3-nitrobenzoic acid (3NB), 2,4-dinitrobenzoic acid (DNB), and 3-toluic acid (3TA) were synthesized by the solvent evaporation method. All the cocrystals were characterized by various analytical techniques, and the crystal structures were determined by the single-crystal X-ray diffraction method (SCXRD). SCXRD analysis revealed that all the synthesized cocrystals were formed through a robust supramolecular acid-amide heterosynthon except the ethenzamide/gallic acid cocrystal, where molecules interacted through OH center dot center dot center dot O hydrogen bond involving -OH of gallic acid and oxygen of amide group of the ETZ molecule. The physicochemical properties such as stability, hygroscopicity, and solubility studies of the ETZ-GA cocrystal were evaluated. It was found that the ETZ-GA cocrystal has a higher solubility (2-fold) than that of the pure ETZ drug molecule. Hygroscopic study of the ETZ-GA cocrystal revealed that synthesized cocrystal was non-hygroscopic at similar to 75% RH conditions. The ETZ-GA cocrystal found to be stable for a time period of four months at ambient temperature.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available